Evidence map›Paper›PMID 40313005›Full record

ArticleHIV medicine2025

Impact of COVID-19 and factors associated with long COVID and COVID-19 vaccine uptake in people with HIV in the United Kingdom: Results from Positive Voices 2022.

F Nakagawa, R Palich, M Kall, J Sewell, C Smith, C Kelly, H Kitt, A Pelchen-Matthews, A Aghaizu, A Sparrowhawk and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

F NakagawaInstitute for Global Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-6646-8744
R PalichInstitute for Global Health, University College London, London, UK.
M KallUK Health Security Agency, London, UK.
J SewellInstitute for Global Health, University College London, London, UK.
C SmithInstitute for Global Health, University College London, London, UK.ORCID https://orcid.org/0000-0003-2847-3355
C KellyUK Health Security Agency, London, UK.
H KittUK Health Security Agency, London, UK.ORCID https://orcid.org/0009-0000-3983-1360
A Pelchen-MatthewsInstitute for Global Health, University College London, London, UK.
A AghaizuUK Health Security Agency, London, UK.
A SparrowhawkGeorge House Trust, Manchester, UK.
N MackieImperial College Healthcare NHS Trust, London, UK.
T DjureticUK Health Security Agency, London, UK.
S SchoemanBrotherton Wing Clinic, Leeds General Infirmary, Leeds, UK.
C HumphreysUK Health Security Agency, London, UK.
M LipmanRespiratory Medicine, University College London, London, UK.
F C LampeInstitute for Global Health, University College London, London, UK.ORCID https://orcid.org/0000-0001-6851-5471
A J RodgerInstitute for Global Health, University College London, London, UK.ORCID https://orcid.org/0000-0001-8817-4651
PV2022 Study Group

Funding

Gilead SciencesNational Institute for Health Research NIHR202038
6 · The paper itself

Abstract

objectivesWe assessed the impact of COVID-19, and the prevalence and factors associated with a history of COVID-19 infection, long COVID and incomplete COVID-19 vaccine uptake among people with HIV.

methodsPositive Voices 2022 is a questionnaire study of people accessing HIV care in the United Kingdom (March 2022-April 2023). Logistic regression assessed factors associated with a history of COVID-19 (previous positive test), long COVID among those with a history of COVID-19 (ongoing symptoms, with COVID-19 onset >3 months previously) and incomplete COVID-19 vaccine uptake (less than three doses of vaccine), adjusted for: age; gender; ethnicity; and year of HIV diagnosis.

resultsIn all, 4188 participants were included. Commonly reported negative impacts of the pandemic were on social contact (44% of participants), mental health (30%), healthcare access (26%) and financial security (25%). Overall, 2068 of 4188 (49.4%) participants had a history of COVID-19. Of these, 10.8% met criteria for long COVID, associated with female gender, unemployment, financial hardship, earlier HIV diagnosis date, diabetes diagnosis, asthma/chronic obstructive pulmonary disease diagnosis, obesity and symptoms of depression and anxiety. Overall, 95.8% reported having at least one vaccine dose, but 649 (15.7%) participants had incomplete vaccine uptake, associated with younger age, female gender, Black African ethnicity, lower education, financial hardship, unemployment, multioccupancy household, more recent HIV diagnosis, detectable HIV viral load and symptoms of depression and anxiety.

conclusionsAbout half of participants had a history of COVID-19, of whom 11% had persistent symptoms (long COVID). COVID-19 vaccine uptake was high, but incomplete uptake was apparent for 16% of participants and was more common among women, younger people, Black African individuals and those with socio-economic disadvantage.

Indexed as

COVID-19COVID-19 VaccinesHIV InfectionsPatient Acceptance of Health CareAdultFemaleHealth Services AccessibilityHumansMaleMiddle AgedRisk FactorsSARS-CoV-2Surveys and QuestionnairesUnited KingdomYoung AdultCOVID-19 VaccinesCOVID‐19HIVlong COVIDvaccination

Identifiers

PMID40313005
PMCPMC12127244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.